摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5,10,15,20,25,30,35,40-八氧杂四十四烷-1,44-二基二丙烯酸酯 | 93982-39-9

中文名称
5,10,15,20,25,30,35,40-八氧杂四十四烷-1,44-二基二丙烯酸酯
中文别名
——
英文名称
5,10,15,20,25,30,35,40-Octaoxatetratetracontane-1,44-diyl diacrylate
英文别名
4-[4-[4-[4-[4-[4-[4-[4-(4-prop-2-enoyloxybutoxy)butoxy]butoxy]butoxy]butoxy]butoxy]butoxy]butoxy]butyl prop-2-enoate
5,10,15,20,25,30,35,40-八氧杂四十四烷-1,44-二基二丙烯酸酯化学式
CAS
93982-39-9
化学式
C42H78O12
mdl
——
分子量
775.1
InChiKey
XIRCRPNSIVRMQI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.4
  • 重原子数:
    54
  • 可旋转键数:
    49
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.86
  • 拓扑面积:
    126
  • 氢给体数:
    0
  • 氢受体数:
    12

文献信息

  • Antibacterial Agent, Substrate Surface Treatment Method Using The Same, Antibacterial Agent Composition, And Substrate Surface Treatment Method Using The Same
    申请人:Komoriya Haruhiko
    公开号:US20130189220A1
    公开(公告)日:2013-07-25
    [Problem] To provide an antibacterial agent which can be limited to the required location on the surface of a material without mixing and has excellent antibacterial, antifungal and antiviral effects even at low concentrations of the active component without elution or volatilization. [Solution] An antibacterial agent that contains as an active component a resin having an organic group represented by general formula (I-1). (In the formula (I-1), R 1 and R 2 mutually independently represent a C 1 -C 4 fluoroalkyl group. “C” and “A” are bonded to each other through a covalent bond or an ionic bond, and “A” represents a hydrogen atom or a cation.)
    [问题] 提供一种抗菌剂,可以将其限制在材料表面的所需位置,而不混合,并且即使在活性成分低浓度下也具有出色的抗菌,抗真菌和抗病毒效果,而不会出现溶出或挥发。 [解决方案] 一种抗菌剂,其包含有机基团为通式(I-1)所表示的树脂作为活性成分。(在通式(I-1)中,R1和R2互相独立地表示C1-C4代烷基。 “C”和“A”通过共价键或离子键彼此连接,“A”表示氢原子或阳离子。)
  • LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL OPTICAL DEVICE
    申请人:Asahi Glass Company, Limited
    公开号:US20170037317A1
    公开(公告)日:2017-02-09
    To provide a high quality liquid crystal optical device irrespective of the size of the liquid crystal optical device, while simplifying the production process, and a liquid crystal composition suitable for such a liquid crystal optical device. The liquid crystal composition of the present invention is a liquid crystal composition comprising a liquid crystal compound which shows liquid crystallinity and which is a non-curable compound, a liquid crystalline curable compound having a polymerizable functional group, and a non-liquid crystalline curable compound having a polymerizable functional group, wherein the content of the non-liquid crystalline curable compound is larger than the content of the liquid crystalline curable compound, and the total amount of the liquid crystalline curable compound and the non-liquid crystalline curable compound is at least 8 mass % and less than 20 mass % of the entirety.
  • PHOTOCURABLE COMPOSITION, DENTURE BASE, AND PLATE DENTURE
    申请人:MITSUI CHEMICALS, INC.
    公开号:US20180014919A1
    公开(公告)日:2018-01-18
    The present invention provides a photocurable composition which is used for the production by stereolithography of a dental prosthesis or the like. This photocurable composition contains a (meth)acrylic monomer component and a photopolymerization initiator; and the (meth)acrylic monomer component contains: an acrylic monomer (X) containing, within one molecule, two aromatic rings and two acryloyloxy groups, and having a Mw of from 400 to 580; and at least one of: a (meth)acrylic monomer (A) containing, within one molecule, one or more ether bonds and two (meth)acryloyloxy groups, and having a Mw of from 200 to 400; a (meth)acrylic monomer (B) not containing, within one molecule, a ring structure other than an aromatic ring and one (meth)acryloyloxy group, and having a Mw of from 130 to 240; or a (meth)acrylic monomer (C) containing, within one molecule, a hydrocarbon skeleton and two (meth)acryloyloxy groups, and having a Mw of from 190 to 280.
  • US9204652B2
    申请人:——
    公开号:US9204652B2
    公开(公告)日:2015-12-08
  • US9976087B2
    申请人:——
    公开号:US9976087B2
    公开(公告)日:2018-05-22
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸